A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Gliosis and Neurodegenerative Diseases: The Role of PET and MR Imaging
2020
Frontiers in Cellular Neuroscience
Glial activation characterizes most neurodegenerative and psychiatric diseases, often anticipating clinical manifestations and macroscopical brain alterations. Although imaging techniques have improved diagnostic accuracy in many neurological conditions, often supporting diagnosis, prognosis prediction and treatment outcome, very few molecular imaging probes, specifically focused on microglial and astrocytic activation, have been translated to a clinical setting. In this context, hybrid
doi:10.3389/fncel.2020.00075
pmid:32327973
pmcid:PMC7161920
fatcat:lkmbgyk3zzbtrkhm4cbkvb4rve